Literature DB >> 9725398

Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury.

M Beghetti1, P E Silkoff, M Caramori, H M Holtby, A S Slutsky, I Adatia.   

Abstract

BACKGROUND: Nitric oxide is an endothelium-derived vasodilator. Cardiopulmonary bypass may induce transient pulmonary endothelial dysfunction with decreased nitric oxide release that contributes to postoperative pulmonary hypertension and lung injury. Exhaled nitric oxide levels may reflect, in part, endogenous production from the pulmonary vascular endothelium.
METHODS: We measured exhaled nitric oxide levels before and 30 minutes after cardiopulmonary bypass in 30 children with acyanotic congenital heart disease and left-to-right intracardiac shunts undergoing repair.
RESULTS: Exhaled nitric oxide levels decreased by 27.6%+/-5.6% from 7+/-0.8 to 4.4+/-0.5 ppb (p < 0.05) 30 minutes after cardiopulmonary bypass despite a reduction in hemoglobin concentration.
CONCLUSIONS: The decrease in exhaled nitric oxide levels suggests reduced nitric oxide synthesis as a result of pulmonary vascular endothelial or lung epithelial injury. This may explain the efficacy of inhaled nitric oxide in the treatment of postoperative pulmonary hypertension. Furthermore, strategies aimed at minimizing endothelial dysfunction and augmenting nitric oxide production during cardiopulmonary bypass may decrease the incidence of postoperative pulmonary hypertension. Exhaled nitric oxide levels may be useful to monitor both cardiopulmonary bypass-induced endothelial injury and the effect of strategies aimed at minimizing such injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725398     DOI: 10.1016/s0003-4975(98)00447-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Review of inhaled nitric oxide in the pediatric cardiac surgery setting.

Authors:  Paul A Checchia; Ronald A Bronicki; Brahm Goldstein
Journal:  Pediatr Cardiol       Date:  2012-04       Impact factor: 1.655

2.  Tidal lung recruitment and exhaled nitric oxide during coronary artery bypass grafting in patients with and without chronic obstructive pulmonary disease.

Authors:  Alysson R Carvalho; Fumito Ichinose; Ivany A Schettino; Dean Hess; Javier Rojas; Antonio Giannella-Neto; Arvind Agnihotri; Jennifer Walker; Thomas E MacGillivray; Marcos F Vidal Melo
Journal:  Lung       Date:  2011-09-28       Impact factor: 2.584

3.  Postoperative Inhaled Nitric Oxide Does Not Decrease Length of Stay in Pediatric Cardiac Surgery Admissions.

Authors:  Joshua Wong; Rohit S Loomba; Lee Evey; Ronald A Bronicki; Saul Flores
Journal:  Pediatr Cardiol       Date:  2019-08-24       Impact factor: 1.655

Review 4.  Early determinants of pulmonary vascular remodeling in animal models of complex congenital heart disease.

Authors:  Sohrab Fratz; Jeffrey R Fineman; Agnes Görlach; Shruti Sharma; Peter Oishi; Christian Schreiber; Thomas Kietzmann; Ian Adatia; John Hess; Stephen M Black
Journal:  Circulation       Date:  2011-03-01       Impact factor: 29.690

5.  Inhaled nitric oxide applications in paediatric practice.

Authors:  A Bernasconi; M Beghetti
Journal:  Images Paediatr Cardiol       Date:  2002-01

6.  Nebivolol compared with metoprolol for erectile function in males undergoing coronary artery bypass graft.

Authors:  Mustafa Aldemir; İbrahim Keleş; Mustafa Karalar; Evren Tecer; Fahri Adalı; Mehmet Bilgehan Pektaş; Ali İhsan Parlar; Osman Tansel Darçın
Journal:  Anatol J Cardiol       Date:  2015-02-11       Impact factor: 1.596

7.  Evaluations of erectile dysfunction before and after on-pump coronary artery bypass graft surgery.

Authors:  Shervin ZiabakhshTabary; Farzad Mokhtari-Esbuie; Mehran Fazli
Journal:  Caspian J Intern Med       Date:  2014
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.